|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3626273 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19197371.8 |
| Date of filing the European patent application | 2017-05-17 | |
| (97) | Date of publication of the European application | 2020-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation | 2021-03-10 |
| (30) | Number | Date | Country code |
| 201662337796 P | 2016-05-17 | US |
| (72) |
REILLY, Edward B, US
NAUMOVSKI, Louie, US
ALLAN, Christian B., US
WANG, Jieyi, US
ANDERSON, Mark G., US
AFAR, Daniel E., US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard, Redwood City, CA 94063, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-cMet antikūnų vaisto konjugatai ir jų naudojimo būdai |
| ANTI-CMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2025-04-09 | 9 | 208.00 EUR |
| 2026-05-17 |